BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 15581975)

  • 21. Prognostic factors and outcome in women with uterine sarcoma.
    Denschlag D; Masoud I; Stanimir G; Gilbert L
    Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators.
    Lim P; Aquino-Parsons CF; Wong F; Dupuis B; Phillips D; Zhou C; Gilks CB
    Gynecol Oncol; 1999 May; 73(2):191-5. PubMed ID: 10329033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?
    Raspollini MR; Susini T; Amunni G; Paglierani M; Taddei A; Marchionni M; Scarselli G; Taddei GL
    Gynecol Oncol; 2005 Jan; 96(1):159-67. PubMed ID: 15589595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).
    Reed NS; Mangioni C; Malmström H; Scarfone G; Poveda A; Pecorelli S; Tateo S; Franchi M; Jobsen JJ; Coens C; Teodorovic I; Vergote I; Vermorken JB;
    Eur J Cancer; 2008 Apr; 44(6):808-18. PubMed ID: 18378136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group.
    Meurer M; Floquet A; Ray-Coquard I; Bertucci F; Auriche M; Cordoba A; Piperno-Neumann S; Salas S; Delannes M; Chevalier T; Italiano A; Blay JY; Mancini J; Pautier P; Duffaud F
    Int J Gynecol Cancer; 2019 May; 29(4):691-698. PubMed ID: 30772825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor.
    Leiser AL; Hamid AM; Blanchard R
    Gynecol Oncol; 2004 Aug; 94(2):567-71. PubMed ID: 15297205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retroperitoneal soft-tissue sarcomas: prognosis and treatment of primary and recurrent disease.
    Bautista N; Su W; O'Connell TX
    Am Surg; 2000 Sep; 66(9):832-6. PubMed ID: 10993610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial stromal neoplasms of the uterus. A clinicopathologic study.
    Sieiński W
    Patol Pol; 1992; 43(1):30-4. PubMed ID: 1296171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer.
    Goudge C; Bernhard S; Cloven NG; Morris P
    Gynecol Oncol; 2004 May; 93(2):536-9. PubMed ID: 15099975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
    Feng W; Hua K; Malpica A; Zhou X; Baak JP
    Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors, treatment and outcome in a Turkish population with endometrial stromal sarcoma.
    Donertas A; Nayki U; Nayki C; Ulug P; Gultekin E; Yildirim Y
    Asian Pac J Cancer Prev; 2015; 16(3):881-7. PubMed ID: 25735377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups.
    Bartosch C; Exposito MI; Lopes JM
    Int J Surg Pathol; 2010 Aug; 18(4):286-91. PubMed ID: 19482859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
    Devins KM; Attygalle AD; Croce S; Vroobel K; Oliva E; McCluggage WG
    Am J Surg Pathol; 2023 Jun; 47(6):717-724. PubMed ID: 37032555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment.
    Beck TL; Singhal PK; Ehrenberg HM; Rose PG; Lele SB; Krivak TC; McBee WC
    Gynecol Oncol; 2012 Apr; 125(1):141-4. PubMed ID: 22119993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
    Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
    Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
    Alektiar KM; Brennan MF; Singer S
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.